Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Operating Leases (2023 - 2025)

Historic Operating Leases for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $108000.0.

  • Rallybio's Operating Leases changed N/A to $108000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108000.0, marking a year-over-year change of. This contributed to the annual value of $392000.0 for FY2023, which is N/A changed from last year.
  • Per Rallybio's latest filing, its Operating Leases stood at $108000.0 for Q3 2025.
  • Rallybio's 5-year Operating Leases high stood at $392000.0 for Q4 2023, and its period low was $58000.0 during Q2 2024.
  • Its 3-year average for Operating Leases is $210285.7, with a median of $211000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Rallybio's Operating Leases was 6386.29% (2024), while the steepest drop was 7819.55% (2024).
  • Rallybio's Operating Leases (Quarter) stood at $392000.0 in 2023, then plummeted by 85.2% to $58000.0 in 2024, then soared by 86.21% to $108000.0 in 2025.
  • Its Operating Leases stands at $108000.0 for Q3 2025, versus $58000.0 for Q2 2024 and $116000.0 for Q1 2024.